In the present study, the characterization of 3 atypical isolates of Actinobacillus pleuropneumoniae is presented. Two isolates (1B and 27E) showed positive reactions in coagglutination, immunodiffusion, and indirect hemagglutination tests for serotypes 1 and 7, whereas the third isolate (26B) reacted with antisera to serotypes 1, 4, and 7. These atypical isolates of A. pleuropneumoniae possessed a capsular polysaccharide (CPS) antigenically related to serotype 1 as well as an O-chain lipopolysaccharide antigenically related to serotype 7 or to serotypes 4 and 7, as shown by the use of monoclonal antibodies. Results of toxin profile and virulence assays for mice and pigs showed them to be more related to A. pleuropneumoniae serotype 7 field isolates. All 3 isolates induced antibodies mainly against serotype 7/4 O-long-chain lipopolysaccharide (LC-LPS) and, to a lesser extent, to the CPS of serotype 1, in experimentally infected pigs. Diagnostic laboratories that use a LC-LPS-based enzyme-linked immunosorbent assay (ELISA) for serodiagnosis of A. pleuropneumoniae infection in swine would probably diagnose herds infected with these atypical isolates as being infected by A. pleuropneumoniae serotypes 7 or 4, whereas those that use a CPS-based ELISA would probably consider them as infected by A. pleuropneumoniae serotype 1.
tibodies has proved to be a superior tool for differentiating several of these isolates. [9] [10] [11] 16, 21 The characterization of 3 selected A. pleuropneumoniae atypical isolates antigenically related to serotypes 1 and 7 is reported in the present study.
In 1997, isolations of A. pleuropneumoniae were attempted from tonsils of clinically healthy animals in 3 different herds of pigs located in Quebec, Canada, using a recently described immunomagnetic method. 5 Despite the fact that animals from these herds presented serologic evidence, using an enzyme-linked immunosorbent assay (ELISA) as diagnostic test, 6, 7 of subclincal infection by A. pleuropneumoniae serotype 7, the isolates were recovered from tonsils with magnetic beads coated with purified polyclonal anti-A. pleuropneumoniae serotype 1 immunoglobulin G (IgG) antibodies. Three of the isolates, namely 27E, 1B, and 26B, representing 3 different herds, were selected for further studies. They were grown at 37 C and 5% CO 2 on PPLO agar a supplemented with NAD as previously described. 11 Serotyping was carried out by coagglutination, immunodiffusion (ID), and indirect hemagglutination (IHA) tests using rabbit hyperimmune sera against reference strains of the 12 serotypes of A. pleuropneumoniae. 15 In addition, the isolates were tested with serotype-specific monoclonal antibodies (MAbs) directed against the CPS and O-chain LPS of A. pleuropneumoniae serotype 1 and 7 9-11 using a dot-ELISA. This test was performed as follows: whole-cell antigen suspensions 15 were adjusted to a McFarland 4 density, placed on nitrocellulose membranes in a 10-l volume, and incubated at room temperature for 15 minutes. Membranes were rinsed with Tris-NaCl buffer and blocked for 1 hour in 2% casein-Tris-NaCl buffer. A 2-hour incubation with the optimally diluted MAbs in 2% casein-Tris-NaCl buffer was followed by a 1-hour incubation of optimally diluted goat anti- Results for the serotyping are shown in Table 1 . Isolates 1B and 27E were positive by all 3 tests using the 1 and 7 antisera. Isolate 26B had a different profile showing positive reactions with anti-serotype 1 serum by all 3 tests, a positive IHA reaction with anti-serotype 7, and positive IHA and ID tests with antiserum against serotype 4. These results indicate the presence of cross-reactions between se-rotypes 1 and 7 for isolates 1B and 27E and between serotypes 1, 7, and 4 for the isolate 26B. Slight cross-reactions between reference strains of serotype 7 and those of serotypes 1, 9, or 11 were previously reported. 13 These re- actions were considered to be the result of minor common antigens, different from those caused by serotype-specific antigens. In fact, when using serotype-specific monoclonal antibodies, no cross-reactions could be detected between serotypes 1 and 7 isolates. [9] [10] [11] In the case of the 3 isolates tested in this study, it was speculated that the observed cross-reactions were strong enough to be caused by serotype-specific antigens. This was confirmed by the use of MAbs, as shown in Figs In order to confirm the reactions as observed in dot-ELISA, an ELISA-inhibition test was carried out. Each MAb diluted at a concentration yielding an optical density (OD 414 ) of approximately 1.0 in an indirect ELISA using the appropriate strain 10 was preincubated for 2 hours at 37 C. This was followed by an overnight incubation at 4 C (serotype 7-specific MAbs) or a 20-minute room temperature incubation (serotype 1-specific MAbs), with whole-cell antigens 15 of A. pleuropneumoniae-positive control strains (reference strains 4074 and WF83 for serotypes 1 and 7, respectively), negative control strain (A. pleuropneumoniae serotype 5b, strain 81-781 9 ) or isolates 1B, 27E, or 26B. After centrifugation, the resulting supernatants were treated the same way, 2 more times. The supernatants were tested in an indirect ELISA using a whole-cell antigen of the corresponding strain used for the production of each MAb. [9] [10] [11] Results indicate that isolates 27E and 1B could inhibit the reactivities of all MAbs at different levels ( Table 2) . Isolate 26B inhibited only 1 of the serotype 1 CPS-specific MAbs as well as the MAb that recognized an epitope in the O-chain LPS of A. pleuropneumoniae serotypes 7 and 4 ( Table 2) . Results obtained by both dot-ELISA and ELISA-inhibition test in-dicated that all 3 isolates possessed serotype 1-related CPS and serotype 7-related O-chain LPS antigens. In addition, isolate 26B also possessed serotype 4-specific O-chain LPS epitopes.
Further characterization of these atypical isolates included genetic fingerprinting by randomly amplified polymorphic DNA (RAPD) analysis, toxin gene profiling, and virulence testing in mice and pigs. The RAPD fingerprinting was carried out as previously described 3 20 The cycling program was identical to that previously described. 3 Amplified products were separated by electrophoresis in a 1.4% agarose gel g and visualized by UV transillumination after ethidium bromide staining. A 1-kb DNA ladder h was used in each gel as a molecular size standard. Photographs of each gel were digitized with a video camera connected to a microcomputer. i Toxin gene typing was done as previously described. 4 This method allows the determination of the activator (C), the structural gene (A), and the secretion genes (B and D) of the 3 toxins ApxI, ApxII, and ApxIII. Briefly, the template DNA was obtained from bacterial cultures with a direct lysis method and multiplex-PCR was carried out with specific oligonucleotide primer pairs for the amplification of apxICA, apxIIICA, apxIBD, and apxIIIBD. The PCR products were separated on a 0.7% (w/v) agarose gel by electrophoresis.
Virulence for mice was evaluated by determining the fifty percent lethal dose (LD 50 ) using intranasal inoculation of 6week-old mice as previously described. 8 In addition, 2 groups of 3 5-week-old specific-pathogen-free pigs were inoculated 3 times intranasally at 2-week intervals and once intravenously, with 5 ϫ 10 8 colony-forming units (CFU)/pig (2 ml/nostril) of a 6-hour culture of isolate 27E and isolate 26B, respectively. Isolate 1B was not tested because it presented characteristics very similar to isolate 27E. A third group was inoculated with a field isolate of A. pleuropneumoniae serotype 1 (isolate 91-6514), as a positive virulence control. Animals were maintained in compliance with the guidelines of the Canadian Council on Animal Care. Clinical signs were recorded 2 times each day and animals were bled 1 time each week. Ten days after the last injection, animals were euthanized and bled. Sera were collected and stored at Ϫ20 C until tested by ELISA using a long-chain LPS (LC-LPS) and purifed CPS. 6, 7 Results of the RAPD showed no differences between isolates 1B and 27B (Fig. 3) , indicating a possible common origin for both isolates. Isolate 26B presented a different profile with 2 of the 3 primers tested (Fig. 3) , confirming results obtained with serotyping and MAbs.
Results from further characterization of isolates are shown in Table 3 . Toxin gene typing revealed a serotype 7 pattern for the 3 isolates. 4 The production of only ApxII was confirmed by the use of monoclonal antibodies (J. Frey, University of Berne, Switzerland, personal communication).
The 3 isolates had an LD 50 for mice typical of serotype 7 isolates. 8 In fact, it was demonstrated that serotype 1 isolates presented a lower LD 50 than serotype 7 isolates. 8 This low virulence was also observed for pigs. After experimental inoculation of more than 10 8 CFU/pig, isolates 27E and 26B were found to be completely avirulent. Infected animals did not present any clinical signs after the challenge. At necropsy, neither macroscopic nor microscopic lesions compatible with swine pleuropneumonia were observed in the challenged animals. On the other hand, animals infected with the serotype 1 virulent isolate 91-6514 presented typical clinical signs of swine pleuropneumonia (fever, reduced appetite, coughing, and difficult breathing). Such animals should be treated with antibiotics to avoid death. At necropsy, typical lesions associated with swine pleuropneumonia were observed.
The humoral response of animals infected with the atypical A. pleuropneumoniae isolates, as evaluated by ELISA, was, in general, low. Four weeks after the first challenge and 2 weeks after the second challenge, only 1 animal of each group had ELISA OD 414 values higher than 0.20 for the serotype 7 LC-LPS ELISA. All pigs were serologically negative for the serotype 7 CPS ELISA as well as for the serotype 1-CPS and LC-LPS ELISA. Two weeks after the intravenous infection, all 3 animals infected with the isolate 27E and 2 animals infected with the isolate 26B presented intermediate OD 414 values (between 0.40 and 0.65) with the serotype 7 LC-LPS. These animals also had low OD 414 values of 0.1-0.3 with the serotype 1-CPS ELISA. Positive reactions were not observed in both serotype 1-LC-LPS ELISA and serotype 7-CPS ELISA. Animals infected with the positive control (isolate 91-6514) presented high OD 414 values (Ն0.80) with the serotype 1-LC-LPS and -CPS ELISA, as expected.
In conclusion, these atypical isolates of A. pleuropneumoniae possess a CPS antigenically related to serotype 1 and an O-chain LPS antigenically related to serotype 7. Similarly, some European strains of A. pleuropneumoniae have been reported to possess capsular antigens antigenically related to serotype 2 and an O-chain LPS related to serotype 7. 18 The toxin profile as well as the low virulence characteristics presented by the isolates described in this study seem to be more related to serotype 7 than to serotype 1 isolates. These field strains were isolated using immunomagnetic beads coated with purified polyclonal anti-A. pleuropneumoniae serotype 1 IgG. 5 Because these isolates possessed serotype 1 CPS-related epitopes, they were easily captured by beads coated with antibodies raised against whole-cell antigen in rabbits; in fact, these antibodies have been shown to be directed to both capsular and somatic epitopes. 15 Based on the proposed new nomenclature, 2, 19 isolates 1B and 27E could antigenically be designated as K1:O7, whereas isolate 26B would be considered as K1:O7/4. Diagnostic laboratories that use LC-LPS-based ELISA may diagnose herds infected with these isolates as being infected by A. pleuropneumoniae serotype 7, whereas those that use CPS-based ELISA will probably consider them as being infected by A. pleuropneumoniae serotype 1.
